Medical Researcher Says DEA Stonewalled Pot Applications

By Sam Reisman (April 13, 2022, 5:42 PM EDT) -- A medical cannabis research lab has filed a new federal lawsuit accusing the U.S. Drug Enforcement Administration of stonewalling its applications to import and study cannabis for potential uses in treating chronic illnesses for the past three years.

In a complaint filed Friday in Rhode Island federal court, affiliated companies MMJ International Holdings Corp. and MMJ BioPharma Cultivation Inc. said the DEA had delayed the process, tying the companies' hands, and recently have refused to give an update despite multiple prods.

"Countless patients who have been affected by multiple sclerosis and Huntington's disease and are waiting on the potentially life-restoring treatments...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!